Soluplus–TPGS Mixed Micelles as a Delivery System for Brigatinib: Characterization and In Vitro Evaluation Article Swipe
Raisuddin Ali
,
Wajhul Qamar
,
Mohd Abul Kalam
,
Ziyad Binkhathlan
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1021/acsomega.4c06264
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1021/acsomega.4c06264
Lung cancer is a major public health concern, with a high incidence and fatality rate. Its treatment is very difficult, as it is mostly diagnosed in advanced stages. Non-small cell lung carcinoma (NSCLC) is the major form of lung carcinoma that persists. Brigatinib (BGT), a powerful small-molecule tyrosine kinase inhibitor, has demonstrated significant therapeutic potential in the treatment of NSCLC with anaplastic lymphoma kinase (ALK) mutations. However, the therapeutic applicability of BGT is hampered by its low solubility and bioavailability. In this study, we developed a mixed micelle system comprising Soluplus and TPGS loaded with BGT. BGT was encapsulated into the mixed micelles using various combinations of Soluplus and TPGS, with encapsulation efficiency (EE%) ranging from 52.43 ± 1.07 to 97.88 ± 2.25%. The dynamic light scattering data showed that the mixed micelles ranged in size from 75.7 ± 0.46 to 204.3 ± 5.40 nm. The selected mixed micelles (F6) showed approximately 38% BGT release in the first 2 h, and subsequently, within 72 h, the release was 94.50 ± 5.90%. The NMR experiment confirmed the formation of micelles. Additionally, the mixed micelles showed significantly higher cellular uptake (p < 0.05) and increased cytotoxicity (p < 0.05) as compared to the free BGT. Specifically, the obtained IC50 values for BGT-loaded Soluplus-TPGS mixed micelles and free BGT were 22.59 ± 6.07 and 61.45 ± 6.35 μg/mL, respectively. The results of the in vitro stability experiment showed that the selected mixed micelle (F6) was stable at both room temperature and 4 °C, with only minor changes in size and PDI. Our results indicate great potential for the developed Soluplus-TPGS mixed micelles as a delivery system for BGT.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1021/acsomega.4c06264
- OA Status
- gold
- Cited By
- 6
- References
- 56
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4402644537
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4402644537Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1021/acsomega.4c06264Digital Object Identifier
- Title
-
Soluplus–TPGS Mixed Micelles as a Delivery System for Brigatinib: Characterization and In Vitro EvaluationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-09-19Full publication date if available
- Authors
-
Raisuddin Ali, Wajhul Qamar, Mohd Abul Kalam, Ziyad BinkhathlanList of authors in order
- Landing page
-
https://doi.org/10.1021/acsomega.4c06264Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1021/acsomega.4c06264Direct OA link when available
- Concepts
-
Characterization (materials science), Micelle, In vitro, Chemistry, Materials science, Nanotechnology, Organic chemistry, Biochemistry, Aqueous solutionTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6Per-year citation counts (last 5 years)
- References (count)
-
56Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4402644537 |
|---|---|
| doi | https://doi.org/10.1021/acsomega.4c06264 |
| ids.doi | https://doi.org/10.1021/acsomega.4c06264 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39398132 |
| ids.openalex | https://openalex.org/W4402644537 |
| fwci | 2.10601949 |
| type | article |
| title | Soluplus–TPGS Mixed Micelles as a Delivery System for Brigatinib: Characterization and In Vitro Evaluation |
| awards[0].id | https://openalex.org/G1600818421 |
| awards[0].funder_id | https://openalex.org/F4320335726 |
| awards[0].display_name | |
| awards[0].funder_award_id | RSPD2024R1097 |
| awards[0].funder_display_name | Deanship of Scientific Research, King Saud University |
| biblio.issue | 40 |
| biblio.volume | 9 |
| biblio.last_page | 41840 |
| biblio.first_page | 41830 |
| topics[0].id | https://openalex.org/T10063 |
| topics[0].field.id | https://openalex.org/fields/25 |
| topics[0].field.display_name | Materials Science |
| topics[0].score | 0.9975000023841858 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2502 |
| topics[0].subfield.display_name | Biomaterials |
| topics[0].display_name | Nanoparticle-Based Drug Delivery |
| topics[1].id | https://openalex.org/T11157 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.996999979019165 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Chronic Lymphocytic Leukemia Research |
| topics[2].id | https://openalex.org/T10602 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.995199978351593 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Glycosylation and Glycoproteins Research |
| funders[0].id | https://openalex.org/F4320335726 |
| funders[0].ror | |
| funders[0].display_name | Deanship of Scientific Research, King Saud University |
| is_xpac | False |
| apc_list.value | 1685 |
| apc_list.currency | USD |
| apc_list.value_usd | 1685 |
| apc_paid.value | 1685 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1685 |
| concepts[0].id | https://openalex.org/C2780841128 |
| concepts[0].level | 2 |
| concepts[0].score | 0.5308089256286621 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5073781 |
| concepts[0].display_name | Characterization (materials science) |
| concepts[1].id | https://openalex.org/C11268172 |
| concepts[1].level | 3 |
| concepts[1].score | 0.47193023562431335 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q421110 |
| concepts[1].display_name | Micelle |
| concepts[2].id | https://openalex.org/C202751555 |
| concepts[2].level | 2 |
| concepts[2].score | 0.4158977270126343 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[2].display_name | In vitro |
| concepts[3].id | https://openalex.org/C185592680 |
| concepts[3].level | 0 |
| concepts[3].score | 0.39306190609931946 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[3].display_name | Chemistry |
| concepts[4].id | https://openalex.org/C192562407 |
| concepts[4].level | 0 |
| concepts[4].score | 0.20427817106246948 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[4].display_name | Materials science |
| concepts[5].id | https://openalex.org/C171250308 |
| concepts[5].level | 1 |
| concepts[5].score | 0.13518312573432922 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[5].display_name | Nanotechnology |
| concepts[6].id | https://openalex.org/C178790620 |
| concepts[6].level | 1 |
| concepts[6].score | 0.10110741853713989 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[6].display_name | Organic chemistry |
| concepts[7].id | https://openalex.org/C55493867 |
| concepts[7].level | 1 |
| concepts[7].score | 0.05167922377586365 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[7].display_name | Biochemistry |
| concepts[8].id | https://openalex.org/C184651966 |
| concepts[8].level | 2 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q906356 |
| concepts[8].display_name | Aqueous solution |
| keywords[0].id | https://openalex.org/keywords/characterization |
| keywords[0].score | 0.5308089256286621 |
| keywords[0].display_name | Characterization (materials science) |
| keywords[1].id | https://openalex.org/keywords/micelle |
| keywords[1].score | 0.47193023562431335 |
| keywords[1].display_name | Micelle |
| keywords[2].id | https://openalex.org/keywords/in-vitro |
| keywords[2].score | 0.4158977270126343 |
| keywords[2].display_name | In vitro |
| keywords[3].id | https://openalex.org/keywords/chemistry |
| keywords[3].score | 0.39306190609931946 |
| keywords[3].display_name | Chemistry |
| keywords[4].id | https://openalex.org/keywords/materials-science |
| keywords[4].score | 0.20427817106246948 |
| keywords[4].display_name | Materials science |
| keywords[5].id | https://openalex.org/keywords/nanotechnology |
| keywords[5].score | 0.13518312573432922 |
| keywords[5].display_name | Nanotechnology |
| keywords[6].id | https://openalex.org/keywords/organic-chemistry |
| keywords[6].score | 0.10110741853713989 |
| keywords[6].display_name | Organic chemistry |
| keywords[7].id | https://openalex.org/keywords/biochemistry |
| keywords[7].score | 0.05167922377586365 |
| keywords[7].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1021/acsomega.4c06264 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210239500 |
| locations[0].source.issn | 2470-1343 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2470-1343 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | ACS Omega |
| locations[0].source.host_organization | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_name | American Chemical Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_lineage_names | American Chemical Society |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ACS Omega |
| locations[0].landing_page_url | https://doi.org/10.1021/acsomega.4c06264 |
| locations[1].id | pmid:39398132 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | ACS omega |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39398132 |
| locations[2].id | pmh:oai:doaj.org/article:32586d9193e1424b852688cb11a371a2 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | ACS Omega, Vol 9, Iss 40, Pp 41830-41840 (2024) |
| locations[2].landing_page_url | https://doaj.org/article/32586d9193e1424b852688cb11a371a2 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11465523 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | ACS Omega |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11465523 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5077764724 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9892-2158 |
| authorships[0].author.display_name | Raisuddin Ali |
| authorships[0].countries | SA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I28022161 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[0].institutions[0].id | https://openalex.org/I28022161 |
| authorships[0].institutions[0].ror | https://ror.org/02f81g417 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I28022161 |
| authorships[0].institutions[0].country_code | SA |
| authorships[0].institutions[0].display_name | King Saud University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Raisuddin Ali |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[1].author.id | https://openalex.org/A5017176576 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6725-0686 |
| authorships[1].author.display_name | Wajhul Qamar |
| authorships[1].countries | SA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I28022161 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[1].institutions[0].id | https://openalex.org/I28022161 |
| authorships[1].institutions[0].ror | https://ror.org/02f81g417 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I28022161 |
| authorships[1].institutions[0].country_code | SA |
| authorships[1].institutions[0].display_name | King Saud University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Wajhul Qamar |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[2].author.id | https://openalex.org/A5086401294 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5713-8858 |
| authorships[2].author.display_name | Mohd Abul Kalam |
| authorships[2].countries | SA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I28022161 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[2].institutions[0].id | https://openalex.org/I28022161 |
| authorships[2].institutions[0].ror | https://ror.org/02f81g417 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I28022161 |
| authorships[2].institutions[0].country_code | SA |
| authorships[2].institutions[0].display_name | King Saud University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mohd Abul Kalam |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[3].author.id | https://openalex.org/A5081963886 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1853-7490 |
| authorships[3].author.display_name | Ziyad Binkhathlan |
| authorships[3].countries | SA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I28022161 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| authorships[3].institutions[0].id | https://openalex.org/I28022161 |
| authorships[3].institutions[0].ror | https://ror.org/02f81g417 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I28022161 |
| authorships[3].institutions[0].country_code | SA |
| authorships[3].institutions[0].display_name | King Saud University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Ziyad Binkhathlan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1021/acsomega.4c06264 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Soluplus–TPGS Mixed Micelles as a Delivery System for Brigatinib: Characterization and In Vitro Evaluation |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10063 |
| primary_topic.field.id | https://openalex.org/fields/25 |
| primary_topic.field.display_name | Materials Science |
| primary_topic.score | 0.9975000023841858 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2502 |
| primary_topic.subfield.display_name | Biomaterials |
| primary_topic.display_name | Nanoparticle-Based Drug Delivery |
| related_works | https://openalex.org/W4387497383, https://openalex.org/W2948807893, https://openalex.org/W2778153218, https://openalex.org/W2748952813, https://openalex.org/W1531601525, https://openalex.org/W4391375266, https://openalex.org/W2078814861, https://openalex.org/W2527526854, https://openalex.org/W1976181487, https://openalex.org/W1986764834 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1021/acsomega.4c06264 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210239500 |
| best_oa_location.source.issn | 2470-1343 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2470-1343 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | ACS Omega |
| best_oa_location.source.host_organization | https://openalex.org/P4310320006 |
| best_oa_location.source.host_organization_name | American Chemical Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| best_oa_location.source.host_organization_lineage_names | American Chemical Society |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ACS Omega |
| best_oa_location.landing_page_url | https://doi.org/10.1021/acsomega.4c06264 |
| primary_location.id | doi:10.1021/acsomega.4c06264 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210239500 |
| primary_location.source.issn | 2470-1343 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2470-1343 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | ACS Omega |
| primary_location.source.host_organization | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_name | American Chemical Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_lineage_names | American Chemical Society |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ACS Omega |
| primary_location.landing_page_url | https://doi.org/10.1021/acsomega.4c06264 |
| publication_date | 2024-09-19 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2210259689, https://openalex.org/W3128646645, https://openalex.org/W4391330294, https://openalex.org/W2062361320, https://openalex.org/W3021050361, https://openalex.org/W2345320779, https://openalex.org/W2604293897, https://openalex.org/W4313830874, https://openalex.org/W2943371561, https://openalex.org/W4385263656, https://openalex.org/W3212716605, https://openalex.org/W2991602328, https://openalex.org/W2910998012, https://openalex.org/W4220964734, https://openalex.org/W3094303934, https://openalex.org/W3100567994, https://openalex.org/W3200894236, https://openalex.org/W2050296608, https://openalex.org/W2802125226, https://openalex.org/W2579811554, https://openalex.org/W3136350349, https://openalex.org/W2811501377, https://openalex.org/W2894230534, https://openalex.org/W2580073024, https://openalex.org/W3093598881, https://openalex.org/W2267336779, https://openalex.org/W2231824866, https://openalex.org/W2768413943, https://openalex.org/W2061215349, https://openalex.org/W1985426192, https://openalex.org/W4281395376, https://openalex.org/W3029386628, https://openalex.org/W3019177222, https://openalex.org/W2040427619, https://openalex.org/W2752704283, https://openalex.org/W4382929920, https://openalex.org/W2099797949, https://openalex.org/W2075440102, https://openalex.org/W2582739159, https://openalex.org/W2496095656, https://openalex.org/W4220840254, https://openalex.org/W2963444325, https://openalex.org/W2015869847, https://openalex.org/W2031104374, https://openalex.org/W2319506065, https://openalex.org/W2042008252, https://openalex.org/W2792423771, https://openalex.org/W2621849512, https://openalex.org/W4322616926, https://openalex.org/W2799569187, https://openalex.org/W2171099227, https://openalex.org/W2071504572, https://openalex.org/W1974373425, https://openalex.org/W2995436453, https://openalex.org/W2793067512, https://openalex.org/W4379662016 |
| referenced_works_count | 56 |
| abstract_inverted_index.2 | 158 |
| abstract_inverted_index.4 | 248 |
| abstract_inverted_index.< | 189, 195 |
| abstract_inverted_index.a | 3, 9, 44, 85, 270 |
| abstract_inverted_index.72 | 163 |
| abstract_inverted_index.In | 80 |
| abstract_inverted_index.as | 20, 197, 269 |
| abstract_inverted_index.at | 243 |
| abstract_inverted_index.by | 74 |
| abstract_inverted_index.h, | 159, 164 |
| abstract_inverted_index.in | 25, 55, 134, 155, 230, 254 |
| abstract_inverted_index.is | 2, 17, 22, 33, 72 |
| abstract_inverted_index.it | 21 |
| abstract_inverted_index.of | 37, 58, 70, 106, 177, 228 |
| abstract_inverted_index.to | 119, 140, 199 |
| abstract_inverted_index.we | 83 |
| abstract_inverted_index.± | 117, 121, 138, 142, 169, 218, 222 |
| abstract_inverted_index.38% | 152 |
| abstract_inverted_index.BGT | 71, 96, 153, 215 |
| abstract_inverted_index.Its | 15 |
| abstract_inverted_index.NMR | 172 |
| abstract_inverted_index.Our | 258 |
| abstract_inverted_index.The | 123, 145, 171, 226 |
| abstract_inverted_index.and | 12, 78, 91, 108, 160, 191, 213, 220, 247, 256 |
| abstract_inverted_index.for | 208, 263, 273 |
| abstract_inverted_index.has | 50 |
| abstract_inverted_index.its | 75 |
| abstract_inverted_index.low | 76 |
| abstract_inverted_index.nm. | 144 |
| abstract_inverted_index.the | 34, 56, 67, 100, 130, 156, 165, 175, 180, 200, 204, 229, 236, 264 |
| abstract_inverted_index.was | 97, 167, 241 |
| abstract_inverted_index.(F6) | 149, 240 |
| abstract_inverted_index.0.46 | 139 |
| abstract_inverted_index.1.07 | 118 |
| abstract_inverted_index.5.40 | 143 |
| abstract_inverted_index.6.07 | 219 |
| abstract_inverted_index.6.35 | 223 |
| abstract_inverted_index.75.7 | 137 |
| abstract_inverted_index.BGT. | 95, 202, 274 |
| abstract_inverted_index.Lung | 0 |
| abstract_inverted_index.PDI. | 257 |
| abstract_inverted_index.TPGS | 92 |
| abstract_inverted_index.both | 244 |
| abstract_inverted_index.cell | 29 |
| abstract_inverted_index.data | 127 |
| abstract_inverted_index.form | 36 |
| abstract_inverted_index.free | 201, 214 |
| abstract_inverted_index.from | 115, 136 |
| abstract_inverted_index.high | 10 |
| abstract_inverted_index.into | 99 |
| abstract_inverted_index.lung | 30, 38 |
| abstract_inverted_index.only | 251 |
| abstract_inverted_index.room | 245 |
| abstract_inverted_index.size | 135, 255 |
| abstract_inverted_index.that | 40, 129, 235 |
| abstract_inverted_index.this | 81 |
| abstract_inverted_index.very | 18 |
| abstract_inverted_index.were | 216 |
| abstract_inverted_index.with | 8, 60, 94, 110, 250 |
| abstract_inverted_index.°C, | 249 |
| abstract_inverted_index.(ALK) | 64 |
| abstract_inverted_index.(EE%) | 113 |
| abstract_inverted_index.0.05) | 190, 196 |
| abstract_inverted_index.204.3 | 141 |
| abstract_inverted_index.22.59 | 217 |
| abstract_inverted_index.52.43 | 116 |
| abstract_inverted_index.61.45 | 221 |
| abstract_inverted_index.94.50 | 168 |
| abstract_inverted_index.97.88 | 120 |
| abstract_inverted_index.NSCLC | 59 |
| abstract_inverted_index.TPGS, | 109 |
| abstract_inverted_index.first | 157 |
| abstract_inverted_index.great | 261 |
| abstract_inverted_index.light | 125 |
| abstract_inverted_index.major | 4, 35 |
| abstract_inverted_index.minor | 252 |
| abstract_inverted_index.mixed | 86, 101, 131, 147, 181, 211, 238, 267 |
| abstract_inverted_index.rate. | 14 |
| abstract_inverted_index.using | 103 |
| abstract_inverted_index.vitro | 231 |
| abstract_inverted_index.(BGT), | 43 |
| abstract_inverted_index.2.25%. | 122 |
| abstract_inverted_index.5.90%. | 170 |
| abstract_inverted_index.cancer | 1 |
| abstract_inverted_index.health | 6 |
| abstract_inverted_index.higher | 185 |
| abstract_inverted_index.kinase | 48, 63 |
| abstract_inverted_index.loaded | 93 |
| abstract_inverted_index.mostly | 23 |
| abstract_inverted_index.public | 5 |
| abstract_inverted_index.ranged | 133 |
| abstract_inverted_index.showed | 128, 150, 183, 234 |
| abstract_inverted_index.stable | 242 |
| abstract_inverted_index.study, | 82 |
| abstract_inverted_index.system | 88, 272 |
| abstract_inverted_index.uptake | 187 |
| abstract_inverted_index.values | 207 |
| abstract_inverted_index.within | 162 |
| abstract_inverted_index.(NSCLC) | 32 |
| abstract_inverted_index.changes | 253 |
| abstract_inverted_index.dynamic | 124 |
| abstract_inverted_index.micelle | 87, 239 |
| abstract_inverted_index.ranging | 114 |
| abstract_inverted_index.release | 154, 166 |
| abstract_inverted_index.results | 227, 259 |
| abstract_inverted_index.stages. | 27 |
| abstract_inverted_index.various | 104 |
| abstract_inverted_index.μg/mL, | 224 |
| abstract_inverted_index.However, | 66 |
| abstract_inverted_index.Soluplus | 90, 107 |
| abstract_inverted_index.advanced | 26 |
| abstract_inverted_index.cellular | 186 |
| abstract_inverted_index.compared | 198 |
| abstract_inverted_index.concern, | 7 |
| abstract_inverted_index.delivery | 271 |
| abstract_inverted_index.fatality | 13 |
| abstract_inverted_index.hampered | 73 |
| abstract_inverted_index.indicate | 260 |
| abstract_inverted_index.lymphoma | 62 |
| abstract_inverted_index.micelles | 102, 132, 148, 182, 212, 268 |
| abstract_inverted_index.obtained | 205 |
| abstract_inverted_index.powerful | 45 |
| abstract_inverted_index.selected | 146, 237 |
| abstract_inverted_index.tyrosine | 47 |
| abstract_inverted_index.(<i>p</i> | 188, 194 |
| abstract_inverted_index.Non-small | 28 |
| abstract_inverted_index.carcinoma | 31, 39 |
| abstract_inverted_index.confirmed | 174 |
| abstract_inverted_index.developed | 84, 265 |
| abstract_inverted_index.diagnosed | 24 |
| abstract_inverted_index.formation | 176 |
| abstract_inverted_index.incidence | 11 |
| abstract_inverted_index.increased | 192 |
| abstract_inverted_index.micelles. | 178 |
| abstract_inverted_index.persists. | 41 |
| abstract_inverted_index.potential | 54, 262 |
| abstract_inverted_index.stability | 232 |
| abstract_inverted_index.treatment | 16, 57 |
| abstract_inverted_index.BGT-loaded | 209 |
| abstract_inverted_index.Brigatinib | 42 |
| abstract_inverted_index.anaplastic | 61 |
| abstract_inverted_index.comprising | 89 |
| abstract_inverted_index.difficult, | 19 |
| abstract_inverted_index.efficiency | 112 |
| abstract_inverted_index.experiment | 173, 233 |
| abstract_inverted_index.inhibitor, | 49 |
| abstract_inverted_index.mutations. | 65 |
| abstract_inverted_index.scattering | 126 |
| abstract_inverted_index.solubility | 77 |
| abstract_inverted_index.significant | 52 |
| abstract_inverted_index.temperature | 246 |
| abstract_inverted_index.therapeutic | 53, 68 |
| abstract_inverted_index.combinations | 105 |
| abstract_inverted_index.cytotoxicity | 193 |
| abstract_inverted_index.demonstrated | 51 |
| abstract_inverted_index.encapsulated | 98 |
| abstract_inverted_index.Additionally, | 179 |
| abstract_inverted_index.Soluplus-TPGS | 210, 266 |
| abstract_inverted_index.Specifically, | 203 |
| abstract_inverted_index.applicability | 69 |
| abstract_inverted_index.approximately | 151 |
| abstract_inverted_index.encapsulation | 111 |
| abstract_inverted_index.respectively. | 225 |
| abstract_inverted_index.significantly | 184 |
| abstract_inverted_index.subsequently, | 161 |
| abstract_inverted_index.small-molecule | 46 |
| abstract_inverted_index.IC<sub>50</sub> | 206 |
| abstract_inverted_index.bioavailability. | 79 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.80018944 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |